Annotations: 4GHA

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	Ebola VP35 IID-like	8092333	3002590	SCOP2B (2022-06-29)
B [auth C]	SCOP2B Superfamily	Ebola VP35 IID-like	8092333	3002590	SCOP2B (2022-06-29)
C [auth E]	SCOP2B Superfamily	Ebola VP35 IID-like	8092333	3002590	SCOP2B (2022-06-29)
D [auth G]	SCOP2B Superfamily	Ebola VP35 IID-like	8092333	3002590	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	Filo_VP35	e4ghaA1	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)
B [auth C]	Filo_VP35	e4ghaC2	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)
C [auth E]	Filo_VP35	e4ghaE2	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)
D [auth G]	Filo_VP35	e4ghaG2	A: a+b complex topology	X: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	H: Polymerase cofactor VP35 C-terminal RNA binding domain (From Topology)	T: Polymerase cofactor VP35 C-terminal RNA binding domain	F: Filo_VP35	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
A	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)
B [auth C]	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
B [auth C]	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)
C [auth E]	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
C [auth E]	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)
D [auth G]	1.10.8.950	Mainly Alpha	Orthogonal Bundle	Helicase, Ruva Protein	domain 3	CATH (4.3.0)
D [auth G]	2.10.10.70	Mainly Beta	Ribbon	Seminal Fluid Protein PDC-109 (Domain B)	Filoviridae VP35, C-terminal inhibitory domain, beta-sheet subdomain	CATH (4.3.0)

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B [auth C], C [auth E], D [auth G]	Polymerase cofactor VP35	-	-	viral nucleocapsid viral capsid virion component host cellular component host intracellular part cellular anatomical structure host cell cytoplasm host cell part host intracellular region
E [auth I], F [auth J]	RNA (5'-R(CPUPAPGPAPCPGPUPCPUPAPG)-3')	-	-	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B [auth C], C [auth E], D [auth G]	IPR031163	Filoviruses VP35 interferon inhibitory domain	Domain
A, B [auth C], C [auth E], D [auth G]	IPR043061	Filoviruses VP35 interferon inhibitory domain, beta-sheet subdomain	Homologous Superfamily
A, B [auth C], C [auth E], D [auth G]	IPR002953	Filoviridae VP35 protein	Family
A, B [auth C], C [auth E], D [auth G]	IPR043060	Filoviruses VP35 interferon inhibitory domain, helical subdomain	Homologous Superfamily

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.